U.S. Launches American Alliance for Biomanufacturing
Slice of Manufacturing Team
May 23, 2025
Key highlights
- Launch of the American Alliance for Biomanufacturing (AAB) to enhance U.S. biomanufacturing capacity and leadership.
- Unified industry response to the National Security Commission on Emerging Biotechnology's call for national strategy.
- Focus on job creation, innovation, and domestic supply chain resilience across critical sectors.
- Biomanufacturing sector valued at $20B globally, with strong growth projections.
- AAB's mission: boost demand and readiness for bio-based products in the U.S.
Notable Quotes
“ Industrial biomanufacturing is no longer just a scientific opportunity – it is a strategic imperative. ”
Ajikumar "Aji" Parayil, CEO at Manus
“ Through strengthening American biomanufacturing, we can deliver better-performing, lower-cost agricultural inputs. ”
Chris Abbott, CEO at Pivot Bio
“ Biomanufacturing gives us the tools to solve real problems in real communities. ”
Tue Michelsen, President at Novonesis North America
Why This Matters
The establishment of the American Alliance for Biomanufacturing (AAB) marks a pivotal shift in U.S. industrial policy toward strengthening biomanufacturing—a sector central to economic security, national defense, and public health. As global competition intensifies, the AAB aims to position the U.S. as a leader in producing sustainable, high-impact bioproducts domestically. This move not only promotes innovation and job creation but also reduces reliance on fragile international supply chains, ensuring a resilient and future-ready American bioeconomy.
